Hypoglycemia with Mealtime Fast-Acting Insulin Aspart vs. Insulin Aspart Across Two Large Type 1 Diabetes Trials

被引：10
|
作者：
De Block, Christophe
Carlson, Anders
Rose, Ludger
Gondolf, Theis
Gorst-Rasmussen, Anders
Lane, Wendy
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-96-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Hypoglycaemia with mealtime fast-acting insulin aspart versus insulin aspart across two large type 1 diabetes trials
    De Block, C.
    Carlson, A.
    Rose, L.
    Gondolf, T.
    Gorst-Rasmussen, A.
    Boesgaard, T. W.
    Lane, W.
    DIABETOLOGIA, 2018, 61 : S31 - S32
  • [2] Cost impact analysis of mealtime fast-acting insulin aspart compared with insulin aspart in adults with Type 1 diabetes in the UK
    Pollock, R. F.
    Parekh, W.
    Watcham, S.
    Hallen, N.
    DIABETIC MEDICINE, 2019, 36 : 166 - 166
  • [3] Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
    Marc Evans
    Mathew Wilkinson
    Angeliki Giannpolou
    Diabetes Therapy, 2019, 10 : 1793 - 1800
  • [4] Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes
    Raskin, P
    Riis, A
    Guthrie, RA
    Jovanovic, L
    Leiter, L
    DIABETES CARE, 2000, 23 (05) : 583 - 588
  • [5] Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
    Evans, Marc
    Wilkinson, Mathew
    Giannpolou, Angeliki
    DIABETES THERAPY, 2019, 10 (05) : 1793 - 1800
  • [6] Improved Glycemic Control with Carbohydrate Counting for Adjustment of Fast-Acting Insulin Aspart vs. Insulin Aspart in Subjects with Type 1 Diabetes
    Philis-Tsimikas, Athena
    Bode, Bruce W.
    Franek, Edward
    Rose, Ludger
    Buchholtz, Kristine
    Demissie, Marek
    Pieber, Thomas R.
    DIABETES, 2017, 66 : A260 - A260
  • [7] Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes
    Bowering, K.
    Harvey, J.
    Kolaczynski, J. W.
    Snyder, J. W.
    Bode, B. W.
    DIABETIC MEDICINE, 2019, 36 (06) : 771 - 775
  • [8] Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart vs insulin aspart in subjects with Type 1 diabetes
    Leelarathna, L.
    Philis-Tsimikas, A.
    Bode, B. W.
    Franek, E.
    Rose, L.
    Buchholtz, K.
    Pieber, T. R.
    DIABETIC MEDICINE, 2018, 35 : 19 - 19
  • [9] ONSET 1: EFFICACY AND SAFETY OF MEALTIME FAST-ACTING INSULIN ASPART VERSUS INSULIN ASPART AFTER 52 WEEKS
    Bode, B.
    Mathieu, C.
    Franek, E.
    Philis-Tsimikas, A.
    Rose, L.
    Graungaard, T.
    Osterskov, A. B.
    Russell-Jones, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A29 - A29
  • [10] Fast-Acting Insulin aspart (faster aspart) - Clinical Data on Application in Type 1 and 2 Diabetes
    Jaeckel, E.
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (06): : 313 - 319
12345